Search Immortality Topics:

Page 420«..1020..419420421422..»

Category Archives: Stem Cell Therapy

New Article from North County Times – BIOTECH: International Stem Cell Clears Debt, Gets Patent

By BRADLEY J. FIKES - [email protected] | Posted: June 15, 2010 3:21 pm |OCEANSIDE ---- For the first time in years, International Stem Cell Corp. has cleared its balance sheet of debt and has enough cash to last for "another … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on New Article from North County Times – BIOTECH: International Stem Cell Clears Debt, Gets Patent

New Article from North County Times – BIOTECH: International Stem Cell Clears Debt, Gets Patent

By BRADLEY J. FIKES - [email protected] | Posted: June 15, 2010 3:21 pm |OCEANSIDE ---- For the first time in years, International Stem Cell Corp. has cleared its balance sheet of debt and has enough cash to last for "another … Continue reading

Posted in Stem Cell Therapy | Comments Off on New Article from North County Times – BIOTECH: International Stem Cell Clears Debt, Gets Patent

Decitabine may target ovarian CSCs?

Two-Drug Phase I Trial Shows Promise in Treating Late-Stage Ovarian Cancer, ScienceDaily, June 13, 2010. Excerpt: "Our hypothesis is that decitabine isn't just targeting active ovarian cancer cells, but also cancer stem cells that seem to survive the first treatments," … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on Decitabine may target ovarian CSCs?

International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’

International Stem Cell Corporation (OTCBB:ISCO), a California-based biotechnology company creating human stem cell lines through its patented parthenogenetic process that requires no use of fertilized embryos, today announced that it is has scheduled a conference call for June 15, 2010 … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’

International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss 'Status of the Company'

International Stem Cell Corporation (OTCBB:ISCO), a California-based biotechnology company creating human stem cell lines through its patented parthenogenetic process that requires no use of fertilized embryos, today announced that it is has scheduled a conference call for June 15, 2010 … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off on International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss 'Status of the Company'

International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’

International Stem Cell Corporation (OTCBB:ISCO), a California-based biotechnology company creating human stem cell lines through its patented parthenogenetic process that requires no use of fertilized embryos, today announced that it is has scheduled a conference call for June 15, 2010 … Continue reading

Posted in Stem Cell Therapy | Comments Off on International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss ‘Status of the Company’